MedPath

An observational validation study of the impact of Frailty on posttreatment adverse events and poor prognosis in patients with a patient with urological diseases

Not Applicable
Conditions
rological diseases
Registration Number
JPRN-UMIN000028533
Lead Sponsor
Hirosaki University Graduate School of Medicine
Brief Summary

The FDS is a reliable and valid tool for assessing frailty and prognosis in patients with urological cancers.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
559
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with urological diseases who could not undergo frailty assessments.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath